Literature DB >> 7110131

Prolactin-deficient variants of GH3 rat pituitary tumor cells: linked expression of prolactin and another hormonally responsive protein in GH3 cells.

R D Ivarie, J A Morris, J A Martial.   

Abstract

GH3 cells normally synthesize and secrete two pituitary polypeptide hormones, prolactin and growth hormone. From an ethyl methane sulfonate-mutagenized population, prolactin low-producing variants have been isolated at a frequency near 20%. Intracellular prolactin synthesis in the variants was reduced 40- to 100-fold compared to wild-type cells while growth hormone synthesis varied less than 2-fold. This decrease was paralleled by a decrease in intracellular preprolactin mRNA. Although reduced, prolactin synthesis was still repressible by glucocorticoids. There was a coordinate loss of expression of p21, a thyroid and glucocorticoid hormone-regulated protein, in GH3 cells, whereas the synthesis and regulation of other hormonally responsive proteins were unimpaired in the variants. Since p21 expression was coordinately regained in a high-producing prolactin revertant cell, expression of the two proteins is tightly coupled in GH3 cells. The stability of the low-producing phenotype differed among variants. One (B2) gave rise to revertants at about 20% frequency even after two rounds of subcloning, whereas another (B3) was more stable in that only 1 weak revertant was found in 47 subclones. The reversion frequency of B3 cells was also measured at less than 0.5%. Unmutagenized GH3 cells were phenotypically stable in that no prolactin-deficient variant was found among 57 subclones. Since variants were ony found after ethyl methane sulfonate mutagenesis, the DNA alkylating agent appears to have promoted an epigenetic change in pituitary gene expression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110131      PMCID: PMC369771          DOI: 10.1128/mcb.2.2.179-189.1982

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Clonal variation in albumin messenger RNA activity in hepatoma cells.

Authors:  J A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

3.  Variation in tyrosine aminotrasferase induction in HTC cell clones.

Authors:  D Aviv; E B Thompson
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

4.  Classifications of anterior pituitary cell types with immunoenzyme histochemistry.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1970-01       Impact factor: 2.479

5.  Effects of thyrotropin-releasing hormone and hydrocortisone on synthesis and degradation of prolactin in a rat pituitary cell strain.

Authors:  P S Dannies; A R Tashjian
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

6.  Establishment of four functional, clonal strains of animal cells in culture.

Authors:  Y Yasamura; A H Tashjian; G H Sato
Journal:  Science       Date:  1966-12-02       Impact factor: 47.728

7.  Thyroid hormone action: a cell-culture system responsive to physiological concentrations of thyroid hormones.

Authors:  H H Samuels; J S Tsai; R Cintron
Journal:  Science       Date:  1973-09-28       Impact factor: 47.728

8.  Measurement of growth hormone synthesis by rat pituitary cells in culture.

Authors:  F C Bancroft
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

9.  Thyroid hormone stimulates de novo growth hormone synthesis in cultured GH1 cells: evidence for the accumulation of a rate limiting RNA species in the induction process.

Authors:  H H Samuels; L E Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

10.  Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells. Differential effects of hydrocortisone and tissue extracts.

Authors:  A H Tashjian; F C Bancroft; L Levine
Journal:  J Cell Biol       Date:  1970-10       Impact factor: 10.539

View more
  8 in total

Review 1.  Control of gene expression by glucocorticoid hormones.

Authors:  G G Rousseau
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

2.  Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor.

Authors:  R D Ivarie; J A Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 3.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Asymmetrical distribution of CpG in an 'average' mammalian gene.

Authors:  M McClelland; R Ivarie
Journal:  Nucleic Acids Res       Date:  1982-12-11       Impact factor: 16.971

5.  The level of expression of the rat growth hormone gene in liver tumor cells is at least eight orders of magnitude less than that in anterior pituitary cells.

Authors:  R D Ivarie; B S Schacter; P H O'Farrell
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

6.  Ethylation of poly(dC-dG).poly(dC-dG) by ethyl methanesulfonate stimulates the activity of mammalian DNA methyltransferase in vitro.

Authors:  I K Farrance; R Ivarie
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Activation of a nonexpressed hypoxanthine phosphoribosyltransferase allele in mutant H23 HeLa cells by agents that inhibit DNA methylation.

Authors:  R Ivarie; J A Morris
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.